According to the website of the State Food and Drug Administration, on June 20, the State Food and Drug Administration held a mobilization and deployment meeting for the consolidation and improvement of drug safety in the national drug supervision system. On the basis of the special drug safety rectification action, the meeting mobilized and deployed the drug safety consolidation and improvement action to further eliminate potential safety hazards, crack down on illegal crimes, improve supervision capabilities, and comprehensively strengthen the bottom line of drug safety.
The meeting requested that the national drug regulatory system should follow the deployment of the "Action Plan for Consolidating and Improving Drug Safety", highlight the key points of work, pay close attention to the implementation of the work, and ensure that the consolidation and improvement actions will achieve tangible results. First, we must highlight the implementation of safety responsibilities, fully implement the main responsibilities of drug safety enterprises, departmental supervision responsibilities, and local party committee and government territorial management responsibilities, and extensively gather joint efforts in drug safety governance. Second, we must highlight the prevention and control of potential safety hazards, strengthen the supervision of key products, key links, and key areas such as high-risk products, selected products in centralized procurement, drug online sales, rural areas and urban-rural junctions, and strive to resolve hidden risks in the bud. Run ahead of the risk. Third, we must focus on cracking down on violations and crimes, strictly grasp the standards of supervision and law enforcement, strengthen supervision or upgrade investigations of major violations of clues, implement the requirements for punishment of illegal acts, and effectively make supervision powerful and law enforcement effective. Fourth, we must highlight and strengthen regulatory coordination, improve and improve working mechanisms such as cross-regional and cross-level drug safety risk consultation, lead transfer, and emergency response, and form a closed-loop regulatory mechanism that is both interconnected and mutually restrained. Fifth, we must highlight the improvement of supervision capabilities, strengthen the construction of technical support capabilities, improve the drug alert system, vigorously develop smart supervision and supervision science, and solidly promote the standardization and standardization of drug supervision capabilities in cities and counties. Sixth, we must highlight the improvement of long-term mechanisms, and further investigate loopholes, make up for shortcomings, and strengths and weaknesses in response to the universal and regular problems exposed by special operations, and comprehensively improve the institutionalization, scientificity, and standardization of supervision.
微信扫一扫打赏
